TY - JOUR T1 - Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (Onset 1). JO - Diabetes Care PY - 2017/04/11 AU - Russell-Jones D AU - Bode BW AU - De Block C AU - Franek E AU - Heller SR AU - Mathieu C AU - Philis-Tsimikas A AU - Rose L AU - Woo VC AU - 脴sterskov AB AU - Graungaard T et al ED - DO - DOI: 10.2337/dc16-1771 Y2 - 2025/03/17 ER -